RGNX
REGENXBIO Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.03
−2.25%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 6.30x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.39x
- Price / sales
- 3.04x
- Price / cash flow
- -2.15x
Enterprise value
- Enterprise value
- $493.5M
- EV / sales
- 2.83x
- EV / EBITDA
- -3.55x
- EV / EBIT
- -3.01x
- Market cap
- $530.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026